Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OTEZLA
- A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
- Apremilast for Erythema Multiforme
- A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
- Adherence to Otezla
- A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
- Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)
- Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy
- A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor
- A Study in Healthy People to Compare 3 Different Formulations of Apremilast Tablets Taken With or Without Food
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- The Maintenance Effect of Enstilar Foam in Combination With Otezla
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
- Apremilast 30 mg BID Combined With Dupilumab
- Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata
- Apremilast - Oral Lichen Planus Trial
- A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Subjects With Manifestations of Plaque Psoriasis and Impaired Quality of Life
- Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.
- Apremilast and Moderate to Severe Chronic Hand Dermatitis
- The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus
- Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis
- Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis
- Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast
- Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis
- Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia
- A Study Examining the Medication Apremilast as Treatment for Chronic Itch
- Medication Development in Alcoholism: Apremilast Versus Placebo
- CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis
- Vascular Inflammation in Psoriasis - Apremilast
- Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy
- Apremilast Pregnancy Exposure Registry
- Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast
- Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
- Treatment With Apremilast in Patients With Psoriatic Arthritis
- A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
- A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
- Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis
- Apremilast in Palmo-Plantar Psoriasis
- A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease
- Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men
- Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
- Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
- Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
- Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
- Apremilast for Atopic Dermatitis - A Pilot Study in Adults
- Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
- Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.
- Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease
- Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
- Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
Clinical trials list
click for details